Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more commonly reported side effects of taking Mounjaro (tirzepatide), recorded in clinical trials and reflected in the medicine's prescribing information. It tends to appear early in treatment or after a dose increase, and for most people it settles within a week or two as the body adjusts. That said, it can be uncomfortable enough to disrupt daily life, and in some cases it warrants medical attention. These are prescription-only medicines; every patient's experience is different, and a GPhC-registered prescriber is best placed to advise on what's normal for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial (the pivotal 72-week study that underpinned Mounjaro's UK approval) recorded gastrointestinal events as the most frequent side effects across all dose groups. Diarrhoea appeared consistently in that profile, alongside nausea, vomiting and constipation, and was more common at higher doses. The NHS medicines page for tirzepatide lists diarrhoea as a common side effect, meaning it affects roughly one in ten people or more. It also appears in Mounjaro's Summary of Product Characteristics published on the electronic Medicines Compendium, which categorises it as common at several dose levels.
Why does it happen? Tirzepatide slows gastric emptying and changes how the gut handles food — this is central to how it works for weight management. Those same effects can speed transit in the large bowel for some people, producing loose or frequent stools. The reaction is pharmacological, not a sign that something has gone wrong with your supply or your pen.
Timing matters more than people expect. The weeks immediately after starting treatment, or after each dose step, carry the highest likelihood of GI disruption. Once the body has had time to adapt, many people find the frequency drops considerably. If you've just moved to a higher strength, a temporary flare of loose stools in the first week or so is consistent with what the trial data show, and our dedicated page on Mounjaro diarrhea goes into further detail on why this happens and what to expect at each stage. Our broader guide to Mounjaro side effects puts this in the wider context of the full GI profile.
There is no single fix, but several adjustments consistently reduce GI disruption for people on GLP-1 and dual-agonist medicines. The most evidence-backed starting point is eating more slowly and in smaller portions, the medicine already slows digestion, and large meals can overwhelm that effect in ways that produce loose stools. High-fat meals are a particular trigger for some people; greasy or very rich food shortly after injection tends to worsen GI symptoms across the board.
Fibre can work both ways. Soluble fibre (oats, lentils, cooked vegetables) tends to bulk and stabilise stools; insoluble fibre in large amounts (raw brassicas, very high-bran foods) can sometimes aggravate things at the start of treatment. Staying well hydrated is not optional, this is the most important practical step if stools are loose, because the fluid lost needs replacing. Plain water is best; caffeine and alcohol can worsen gut motility further.
Some people find that keeping a rough food diary for the first few weeks helps identify a particular meal type or time-of-day pattern. If you inject on a Monday, for instance, tracking whether Tuesday or Wednesday tends to be worse can help you plan around it. It's a small thing, but adjusting what you eat on injection day or the day after has made a real difference for some patients. For more on managing symptoms when your body is already under strain, the page on taking Mounjaro when you're unwell covers the overlap between illness and GI side effects in detail.
Most diarrhoea during Mounjaro treatment resolves without intervention. But there are clear situations where you should contact a healthcare professional rather than waiting it out.
Get prompt medical help if diarrhoea is severe (many loose stools in a day), persists beyond four or five days without improvement, or is accompanied by signs of dehydration: feeling lightheaded when standing, very dark urine, a dry mouth, or noticeable fatigue. Children and older adults dehydrate faster, act sooner if either is affected. Diarrhoea combined with significant abdominal or back pain is a different matter entirely: severe, persistent stomach pain that spreads to the back can occasionally signal pancreatitis, a rare but serious reaction that the MHRA highlighted in a January 2026 Drug Safety Update for GLP-1 medicines. It requires urgent assessment, not watchful waiting.
Blood in stools, or diarrhoea following a recent change to other medications, also warrants a call to your GP or prescriber rather than self-management. If you're unsure whether what you're experiencing is within normal range, that uncertainty is itself a reason to check. Our team can be reached through the contact page, and our clinical team is available for aftercare seven days a week. Suspected side effects can also be reported directly to the MHRA via the Yellow Card scheme, this reporting helps regulators track real-world safety signals across the whole patient population.
A Mounjaro consultation isn't just about confirming eligibility. A prescriber who knows your full health picture (existing gut conditions, other medicines, your typical diet) can set realistic expectations for GI side effects and flag in advance if your circumstances increase the likelihood of a difficult adjustment period. People with a history of irritable bowel syndrome or inflammatory bowel disease, for example, may need closer monitoring during dose escalation.
If diarrhoea is severe enough to affect your quality of life during treatment, that's a conversation worth having rather than simply stopping the medicine. A prescriber can consider whether the pace of titration is right for you or whether any co-prescribed medicines are contributing. Stopping abruptly is rarely the right answer, but continuing through significant distress without support isn't ideal either. The full safety profile of Mounjaro is worth reading alongside this page, and our broader side-effects guide covers the complete list of what to expect during treatment, including less commonly discussed reactions such as the Mounjaro vulva side effect that some patients have reported. If you haven't yet started and want to understand how our prescribers approach these conversations, speak to our prescribers as part of a free consultation, suitability and side effects are discussed before any prescription is issued.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.